Shahida Syed

Global AMR Innovation Fund

Shahida leads the Global AMR Innovation Fund (GAMRIF) which is a £50m UK government aid investment into underinvested early stage antimicrobial resistance (AMR) R&D for the benefit of people on developing countries. Funding research across the world to reduce the threat of AMR, GAMRIF takes a One Health approach supporting research into human and animal health and the environment. Over the past 5 years, Shahida has coordinated the design of a diverse research portfolio in collaboration with partners across the world. In her current role, she oversees the strategic delivery of GAMRIF to maximise the impact and access of AMR-specific innovations. Shahida has a research background in diagnostics research, with a PhD from the University of Edinburgh in Scotland and an MSc in Engineering from the Royal Institute of Technology in Stockholm and the ETH Zurich in Switzerland. She has over 8 years of experience developing antibody- and DNA-based diagnostic technologies in academia and industry.